IRI Separation Technologies Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • PIPE

  • Financing Rounds
  • 5

  • Investments
  • 2

IRI Separation Technologies General Information

Description

Provider of biotechnology research services. The company is engaged in the development and extraction of biotechnology products such as monoclonal and polyclonal immunoglobulin antibodies for virus and bacteria related health issues.

Contact Information

Formerly Known As
Immuno Research
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 3168 Deer Ridge Drive
  • West Vancouver, British Columbia V7S 4W1
  • Canada
Primary Industry
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 3168 Deer Ridge Drive
  • West Vancouver, British Columbia V7S 4W1
  • Canada

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

IRI Separation Technologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore IRI Separation Technologies‘s full profile, request access.

Request a free trial

IRI Separation Technologies Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

IRI Separation Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2712375-A1 A method for commercial isolation of egg yolk igy, its product, and uses of the product Inactive 19-Jan-2007

IRI Separation Technologies Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore IRI Separation Technologies‘s full profile, request access.

Request a free trial

IRI Separation Technologies Acquisitions (2)

IRI Separation Technologies’s most recent deal was a Merger/Acquisition with Enerex Botanicals for . The deal was made on 06-Nov-2007.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Enerex Botanicals 06-Nov-2007 Merger/Acquisition Other Pharmaceuticals and Biotechnology
Simplimix Food 01-Jan-2006 Merger/Acquisition Food Products
To view IRI Separation Technologies’s complete acquisitions history, request access »

IRI Separation Technologies FAQs

  • When was IRI Separation Technologies founded?

    IRI Separation Technologies was founded in 2001.

  • Where is IRI Separation Technologies headquartered?

    IRI Separation Technologies is headquartered in West Vancouver, Canada.

  • What industry is IRI Separation Technologies in?

    IRI Separation Technologies’s primary industry is Biotechnology.

  • Is IRI Separation Technologies a private or public company?

    IRI Separation Technologies is a Private company.

  • What is IRI Separation Technologies’s current revenue?

    The current revenue for IRI Separation Technologies is .

  • How much funding has IRI Separation Technologies raised over time?

    IRI Separation Technologies has raised $10.3M.

  • Who are IRI Separation Technologies’s investors?

    Lakota Research International has invested in IRI Separation Technologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »